ESR1 and breast carcinoma: To determine the effect of directly targeting 4EBP1 in breast cancer cells, we first tested the two ER+ 8p11-p12 cell lines, SUM-44 and Cama-1, and used lentiviral vectors for two different shRNAs against EIF4EBP1.